Corporate Overview and Mission Statement
With corporate headquarters in Houston, TX and R&D laboratories located in Ithaca, NY, MicroBios, Inc. is a leading-edge biotechnology company founded in 2006. Aiming to become the pre-eminent provider of advanced diagnostic, healthcare and environmental products and services, the company is actively engaged in discovering, developing and commercializing innovative technologies which harness the unique metabolic/biochemical/ultrastructural properties of microorganisms.
With its diverse staff of Ph.D. scientists, MicroBios conducts both internal and contract R&D activities in a wide range of technological areas, including animal/human probiotic development, environmental bioremediation and nanobiotechnology. In addition, we also provide scientific and IP consulting services to private sector and government clients seeking expert opinions on a variety of biotechnology-related subjects.
Business Strategy
Key elements of MicroBios’ business strategy include:
- Developing new microbial-, protein- and nucleic acid-based technologies
- Developing unique commercial applications
- Acquiring existing products to expand revenues
- Establishing strategic alliances with industrial partners
- Establishing research collaborations with academic institutions
- Licensing technology for new products
Alliances and Collaborations
- Tetragenetics, Inc. (Ithaca, NY) — Development of an optimized fermentation process for the high-level production of therapeutic proteins and vaccines using improved strains of Tetrahymena thermophila.
- Microbial Research Consulting (Ithaca, NY) — Development of agricultural-based microbial products.
IP Portfolio
Please contact MicroBios to obtain a current listing of our patents and to inquire about licensing opportunities.






